POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can engineered immune cells outsmart transplant-related cancer?
Disease control CompletedThis early-phase trial tests a new type of immunotherapy for people who develop a rare blood cancer called post-transplant lymphoproliferative disease (PTLD) after a solid organ transplant. The treatment uses the patient's own immune cells (T-cells) that are engineered to resist …
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Phase: EARLY_PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Immune cell therapy shows promise for Post-Transplant cancer
Disease control CompletedThis study tested whether specially treated donor white blood cells could help treat a type of lymph cancer that sometimes occurs after an organ transplant. The cancer is linked to the Epstein-Barr virus. Fifty transplant recipients took part. The goal was to see if adding these …
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Phase: PHASE3 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC